Machine learning prediction of early recurrence after surgery for gallbladder cancer.

Journal: The British journal of surgery
PMID:

Abstract

BACKGROUND: Gallbladder cancer is often associated with poor prognosis, especially when patients experience early recurrence after surgery. Machine learning may improve prediction accuracy by analysing complex non-linear relationships. The aim of this study was to develop and evaluate a machine learning model to predict early recurrence risk after resection of gallbladder cancer.

Authors

  • Giovanni Catalano
    Department of Surgery, Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Laura Alaimo
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Odysseas P Chatzipanagiotou
    First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
  • Andrea Ruzzenente
    Department of Surgery, University of Verona, Verona, Italy.
  • Federico Aucejo
    Department of Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Hugo P Marques
    Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
  • Vincent Lam
    Department of Surgery, Westmead Hospital, Sydney, NSW, Australia.
  • Tom Hugh
    Department of Surgery, The University of Sydney, School of Medicine, Sydney, NSW, Australia.
  • Nazim Bhimani
    Department of Surgery, University of Sydney, School of Medicine, Sydney, New South Wales, Australia.
  • Shishir K Maithel
    Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA. Electronic address: smaithe@emory.edu.
  • Minoru Kitago
    Department of Surgery, Keio University, Tokyo, Japan.
  • Itaru Endo
    Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
  • Timothy M Pawlik
    Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, Columbus, OH.